FDA.reportPublic FDA data

brinzolamide 1 % Ophthalmic Suspension

RxCUI
308805
RxNorm name
brinzolamide 1 % Ophthalmic Suspension
Display name
brinzolamide 1 % Ophthalmic Suspension
Full name
brinzolamide 1 % Ophthalmic Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BRINZOLAMIDEBRINZOLAMIDEOceanside Pharmaceuticals.fb7229d4-522e-4cb2-b513-9d34f3ded5912026-04-20Warnings, Adverse reactionsExact identifier
rxcui: 308805
BRINZOLAMIDEBRINZOLAMIDEPadagis US LLCb56a2e4b-7502-4831-a5b1-0370bdb987b12024-08-31Warnings, Adverse reactionsExact identifier
rxcui: 308805
BRINZOLAMIDEBRINZOLAMIDEBausch & Lomb Incorporated37b19837-fcab-4536-abad-6f4f92dfe7942024-07-10Warnings, Adverse reactionsExact identifier
rxcui: 308805
BRINZOLAMIDEBRINZOLAMIDEBryant Ranch Prepack460baf5f-1d47-4ae0-b635-84507c3b028d2023-12-19Warnings, Adverse reactionsExact identifier
rxcui: 308805
AzoptBRINZOLAMIDESandoz Inc0afb6589-51ba-432c-aed1-20a12d5d34552023-11-24Warnings, Adverse reactionsExact identifier
rxcui: 308805
BrinzolamideBRINZOLAMIDESandoz Inced6dbc25-47d7-42db-9787-5814d71f45ce2023-06-30Warnings, Adverse reactionsExact identifier
rxcui: 308805

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 6 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
460baf5f-1d47-4ae0-b635-84507c3b028dbrinzolamide 1 % Ophthalmic Suspension [PSN] · brinzolamide 10 MG/ML Ophthalmic Suspension [SCD] · brinzolamide 1 % Ophthalmic Suspension [SY]3100These highlights do not include all the information needed to use BRINZOLAMIDE OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for BRINZOLAMIDE OPHTHALMIC SUSPENSION. BRINZOLAMIDE ophthalmic suspension 1%, for topical ophthalmic use Initial U.S. Approval: 199820231219
37b19837-fcab-4536-abad-6f4f92dfe794brinzolamide 1 % Ophthalmic Suspension [PSN] · brinzolamide 10 MG/ML Ophthalmic Suspension [SCD] · brinzolamide 1 % Ophthalmic Suspension [SY]37These highlights do not include all the information needed to use BRINZOLAMIDE OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for BRINZOLAMIDE OPHTHALMIC SUSPENSION. BRINZOLAMIDE ophthalmic suspension 1%, for topical ophthalmic use Initial U.S. Approval: 199820240710
b56a2e4b-7502-4831-a5b1-0370bdb987b1brinzolamide 1 % Ophthalmic Suspension [PSN] · brinzolamide 10 MG/ML Ophthalmic Suspension [SCD] · brinzolamide 1 % Ophthalmic Suspension [SY]34These highlights do not include all the information needed to use BRINZOLAMIDE OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for BRINZOLAMIDE OPHTHALMIC SUSPENSION. BRINZOLAMIDE ophthalmic suspension 1%, for topical ophthalmic use Initial U.S. Approval: 199820240831
ed6dbc25-47d7-42db-9787-5814d71f45cebrinzolamide 1 % Ophthalmic Suspension [PSN] · brinzolamide 10 MG/ML Ophthalmic Suspension [SCD] · brinzolamide 1 % Ophthalmic Suspension [SY]34These highlights do not include all the information needed to use BRINZOLAMIDE OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for BRINZOLAMIDE OPHTHALMIC SUSPENSION. BRINZOLAMIDE ophthalmic suspension 1%, for topical ophthalmic use Initial U.S. Approval: 199820230630
fb7229d4-522e-4cb2-b513-9d34f3ded591brinzolamide 1 % Ophthalmic Suspension [PSN] · brinzolamide 10 MG/ML Ophthalmic Suspension [SCD] · brinzolamide 1 % Ophthalmic Suspension [SY]32These highlights do not include all the information needed to use BRINZOLAMIDE OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for BRINZOLAMIDE OPHTHALMIC SUSPENSION. BRINZOLAMIDE ophthalmic suspension 1%, for topical ophthalmic use Initial U.S. Approval: 199820260420
0afb6589-51ba-432c-aed1-20a12d5d3455brinzolamide 1 % Ophthalmic Suspension [PSN] · brinzolamide 10 MG/ML Ophthalmic Suspension [SCD] · brinzolamide 1 % Ophthalmic Suspension [SY]31These highlights do not include all the information needed to use AZOPT safely and effectively. See full prescribing information for AZOPT. AZOPT ® (brinzolamide ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval: 199820231124